{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T03:09:10Z","timestamp":1722222550244},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T00:00:00Z","timestamp":1173052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3,15]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>An aberrant T cell population is the basis for diagnosis of refractory coeliac disease and determines the risk of enteropathy-associated T cell lymphoma. This disease is serious with a poor survival. Pathogenetic mechanisms sustaining aberrant T cell proliferation remain unknown. Recently, alemtuzumab has been proposed as a promising new approach to treat these patients. Only few single cases have been tested at present; nevertheless, in all the cases a clinical improvement was observed. However, whether intraepithelial lymphocytes have been targeted effectively by alemtuzumab is still debated. This study reports, using two-dimensional difference gel electrophoresis (2D DIGE), hyperexpressed proteins associated specifically with aberrant T cells found in a patient with coeliac disease by comparison of the protein expression of this sample with that of patients with coeliac disease and polyclonal T cells or with control subjects. The data demonstrated a significantly higher expression of IgM, apolipoprotein C-III and Charcot\u2013Leyden crystal proteins in a duodenal biopsy specimen of the patient with clonal T cells compared with that of other patients. These preliminary results allow hypothesizing different clinical effects of alemtuzumab in patients with coeliac disease and aberrant T cell proliferation, because as well as the probable effect on T cells, alemtuzumab could exert its effect by acting on inflammatory associated CD52+\u2003IgM+\u2003B cells and eosinophil cells, known to produce IgM and Charcot\u2013Leyden crystal proteins, that we demonstrated to be altered in this patient. The results also emphasize the possible association of apolipoprotein with aberrant T cell proliferation.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2007.03348.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T14:29:41Z","timestamp":1281623381000},"page":"402-409","source":"Crossref","is-referenced-by-count":14,"title":["Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells"],"prefix":"10.1093","volume":"148","author":[{"given":"V","family":"De Re","sequence":"first","affiliation":[{"name":"Farmacologia Sperimentale e clinica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M P","family":"Simula","sequence":"additional","affiliation":[{"name":"Farmacologia Sperimentale e clinica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Caggiari","sequence":"additional","affiliation":[{"name":"Farmacologia Sperimentale e clinica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Orzes","sequence":"additional","affiliation":[{"name":"Servizio di Endoscopia Digestiva\u2013Gastroenterologia, Presidio Ospedaliero, Gorizia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Spina","sequence":"additional","affiliation":[{"name":"Oncologia medica A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Da ponte","sequence":"additional","affiliation":[{"name":"Servizio Immunotrasfusionale ed Analisi Cliniche"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"De Appollonia","sequence":"additional","affiliation":[{"name":"Servizio Immunotrasfusionale ed Analisi Cliniche"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Dolcetti","sequence":"additional","affiliation":[{"name":"Immunologia e bioterapia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Canzonieri","sequence":"additional","affiliation":[{"name":"Anatomia Patologica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Cannizzaro","sequence":"additional","affiliation":[{"name":"Gastroenterologia Oncologica, Centro di Riferimento Oncologico, Aviano (PN)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,3,5]]},"reference":[{"key":"2022010414515222400_b1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T cell lymphoma","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"2022010414515222400_b2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat Med"},{"key":"2022010414515222400_b3","doi-asserted-by":"crossref","first-page":"12390","DOI":"10.1073\/pnas.2135229100","article-title":"The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses","volume":"100","author":"Vader","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010414515222400_b4","first-page":"A","article-title":"Alemtuzumab treatment of refractory celiac disease type II","volume":"130","author":"Lundin","year":"2006","journal-title":"Gastroenterology"},{"key":"2022010414515222400_b5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMc061784","article-title":"Alemtuzumab for refractory celiac disease","volume":"355","author":"Verbeek","year":"2006","journal-title":"N Engl J Med"},{"key":"2022010414515222400_b6","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1056\/NEJMc053129","article-title":"Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T cell lymphoma","volume":"354","author":"Vivas","year":"2006","journal-title":"N Engl J Med"},{"key":"2022010414515222400_b7","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood.V99.10.3554","article-title":"Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study","volume":"99","author":"Keating","year":"2002","journal-title":"Blood"},{"key":"2022010414515222400_b8","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.1998.16.10.3257","article-title":"CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study","volume":"16","author":"Lundin","year":"1998","journal-title":"J Clin Oncol"},{"key":"2022010414515222400_b9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022010414515222400_b10","doi-asserted-by":"crossref","DOI":"10.1016\/S1590-8658(07)80014-4","article-title":"Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus","volume-title":"Dig Liver Dis","author":"De Re"},{"key":"2022010414515222400_b11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/rheumatology\/kei278","article-title":"Type II. mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses","volume":"45","author":"De Re","year":"2006","journal-title":"Rheumatology"},{"key":"2022010414515222400_b12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/gut.27.10.1151","article-title":"Immunoglobulin production by coeliac biopsies in organ culture","volume":"27","author":"Wood","year":"1986","journal-title":"Gut"},{"key":"2022010414515222400_b13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.32.1.29","article-title":"Dissociation between systemic and mucosal humoral immune responses in coeliac disease","volume":"32","author":"O'Mahony","year":"1991","journal-title":"Gut"},{"key":"2022010414515222400_b14","first-page":"123","article-title":"Jejunal plasma cells and in vitro immunoglobulin production in adult coeliac disease","volume":"69","author":"Wood","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"2022010414515222400_b15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/gut.18.11.887","article-title":"Immunoglobulins in the jejunal mucosa in adult coeliac disease and dermatitis herpetiformis after the reintroduction of dietary gluten","volume":"18","author":"Lancaster-Smith","year":"1977","journal-title":"Gut"},{"key":"2022010414515222400_b16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/jcp.29.7.587","article-title":"Cellular infiltrate of the jejunum after re-introduction of dietary gluten in children with treated coeliac disease","volume":"29","author":"Lancaster-Smith","year":"1976","journal-title":"J Clin Pathol"},{"key":"2022010414515222400_b17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0016-5085(90)91020-7","article-title":"Secretory immunity in celiac disease: cellular expression of immunoglobulin A subclass and joining chain","volume":"99","author":"Kett","year":"1990","journal-title":"Gastroenterology"},{"key":"2022010414515222400_b18","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/0016-5085(89)90406-X","article-title":"Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes","volume":"97","author":"Brandtzaeg","year":"1989","journal-title":"Gastroenterology"},{"key":"2022010414515222400_b19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.30.3.347","article-title":"Immunoglobulin secretion by isolated intestinal lymphocytes: spontaneous production and T cell regulation in normal small intestine and in patients with coeliac disease","volume":"30","author":"Crabtree","year":"1989","journal-title":"Gut"},{"key":"2022010414515222400_b20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/path.1711210405","article-title":"Jejunal mucosal immunoglobulins and complement in untreated coeliac disease","volume":"121","author":"Scott","year":"1977","journal-title":"J Pathol"},{"key":"2022010414515222400_b21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0016-5085(92)90155-R","article-title":"Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease","volume":"102","author":"Halstensen","year":"1992","journal-title":"Gastroenterology"},{"key":"2022010414515222400_b22","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.239.19.2019","article-title":"Dermatitis herpetiformis and celiac disease: association with glomerulonephritis, hypocomplementia, and circulating immune complexes","volume":"239","author":"Moorthy","year":"1978","journal-title":"JAMA"},{"key":"2022010414515222400_b23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0016-5085(90)90958-4","article-title":"Gliadin challenge-induced jejunal prostaglandin E2 secretion in celiac disease","volume":"99","author":"Lavo","year":"2006","journal-title":"Gastroenterology"},{"key":"2022010414515222400_b24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0002-9343(89)90230-1","article-title":"Studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents","volume":"86","author":"Hallgren","year":"1989","journal-title":"Am J Med"},{"key":"2022010414515222400_b25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/gut.2004.057174","article-title":"TI\u2003\u2212\u2003gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn","volume":"54","author":"Kristjansson","year":"2005","journal-title":"Gut"},{"key":"2022010414515222400_b26","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/gut.33.9.1190","article-title":"Evidence for a local release of major basic protein","volume":"33","author":"Colombel","year":"1992","journal-title":"Gut"},{"key":"2022010414515222400_b27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1194\/jlr.M500455-JLR200","article-title":"Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism","volume":"47","author":"Mauger","year":"2006","journal-title":"J Lipid Res"},{"key":"2022010414515222400_b28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"TI\u2003\u2212\u2003effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"2022010414515222400_b29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00041433-200310000-00004","article-title":"TI\u2003\u2212\u2003oxidized low density lipoprotein and innate immune receptors","volume":"14","author":"Miller","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"2022010414515222400_b30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pmic.200300938","article-title":"Mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry","volume":"5","author":"Karlsson","year":"2005","journal-title":"Proteomics"},{"key":"2022010414515222400_b31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"2022010414515222400_b32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/gerona\/58.6.M561","article-title":"Effect of plasma lipoproteins on natural killer cell activity in the elderly population","volume":"58","author":"Yasumasu","year":"2006","journal-title":"J Gerontol A Biosci Med Sci"},{"key":"2022010414515222400_b33","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1172\/JCI1216","article-title":"TI\u2003\u2212\u2003hypercholesterolemia is associated with a T helper (Th)1\/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice","volume":"101","author":"Zhou","year":"1998","journal-title":"J Clin Invest"},{"key":"2022010414515222400_b34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-2275(20)38390-5","article-title":"TI\u2003\u2212\u2003effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins","volume":"30","author":"Cabana","year":"1989","journal-title":"J Lipid Res"},{"key":"2022010414515222400_b35","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0022-2275(20)35355-4","article-title":"Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters","volume":"34","author":"Feingold","year":"2006","journal-title":"J Lipid Res"},{"key":"2022010414515222400_b36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0026-0495(88)90120-5","article-title":"Changes in serum lipoprotein pattern induced by acute infections","volume":"37","author":"Sammalkorpi","year":"2006","journal-title":"Metabolism"},{"key":"2022010414515222400_b37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2362.1996.00100.x","article-title":"TI\u2003\u2212\u2003co-regulation of apo A-I, apo C-III and apo A-IV gene expression in human intestinal biopsies","volume":"26","author":"Metzger","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"2022010414515222400_b38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20060028","article-title":"TI\u2003\u2212\u2003reprogramming of CTLs into natural killer-like cells in celiac disease","volume":"203","author":"Meresse","year":"2006","journal-title":"J Exp Med"},{"key":"2022010414515222400_b39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"TI\u2003\u2212\u2003a direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"Hue","year":"2004","journal-title":"Immunity"},{"key":"2022010414515222400_b40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1074-7613(00)80174-0","article-title":"TI\u2003\u2212\u2003murine CD1d-restricted T cell recognition of cellular lipids","volume":"12","author":"Gumperz","year":"2000","journal-title":"Immunity"},{"key":"2022010414515222400_b41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1385\/IR:33:3:241","article-title":"TI\u2003\u2212\u2003role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity","volume":"33","author":"Champagne","year":"2005","journal-title":"Immunol Res"},{"key":"2022010414515222400_b42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.immuni.2004.11.012","article-title":"TI\u2003\u2212\u2003tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I","volume":"22","author":"Scotet","year":"2005","journal-title":"Immunity"},{"key":"2022010414515222400_b43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2741\/1556","article-title":"TI\u2003\u2212\u2003synergism and complementarity between human CD1 and MHC-restricted T cells, two lymphoid subsets directed against distinct antigenic worlds","volume":"10","author":"Bonneville","year":"2005","journal-title":"Front Biosci"},{"key":"2022010414515222400_b44","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1074\/jbc.M200221200","article-title":"TI\u2003\u2013 Charcot\u2013Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion","volume":"277","author":"Ackerman","year":"2002","journal-title":"J Biol Chem"},{"key":"2022010414515222400_b45","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1152\/ajpgi.00015.2005","article-title":"Role for major basic protein","volume":"289","author":"Furuta","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022010414515222400_b46","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/archinte.163.11.1371-a","article-title":"Clinical revision of 1862 cases","volume":"63","author":"Lombardi","year":"2003","journal-title":"Arch Intern Med"},{"key":"2022010414515222400_b47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1084\/jem.175.1.293","article-title":"TI\u2003\u2212\u2003interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease","volume":"175","author":"Desreumaux","year":"1992","journal-title":"J Exp Med"},{"key":"2022010414515222400_b48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1749-6632.1996.tb32582.x","article-title":"TI\u2003\u2212\u2003synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils","volume":"796","author":"Lamkhioued","year":"1996","journal-title":"Ann NY Acad Sci"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2007.03348.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/148\/3\/402\/42054316\/j.1365-2249.2007.03348.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/148\/3\/402\/42054316\/j.1365-2249.2007.03348.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T14:58:48Z","timestamp":1641308328000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/148\/3\/402\/6457801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,5]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,3,5]]},"published-print":{"date-parts":[[2007,3,15]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03348.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,6]]},"published":{"date-parts":[[2007,3,5]]}}}